C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates

Area of Science:

• Immunology
• Biochemistry

Background:

• The classical complement pathway is crucial for immune responses.
• Soluble immune complexes can trigger complement activation.
• C1-inhibitor (C1-In) is a key regulator of complement.

Purpose of the Study:

• To investigate the role of C1-inhibitor in the classical complement pathway activation by soluble immune complexes.
• To elucidate the mechanism by which C1-In regulates this process.

Main Methods:

• Utilized purified human complement components (C1, C4, C1-In).
• Employed stabilized soluble IgG aggregates as model immune complexes.
• Conducted kinetic studies and C4 consumption assays.

Main Results:

• C1-In irreversibly inactivates C1 through a second-order reaction.
• C1-In significantly reduces the efficiency of complement activation by immune complexes.
• C1-In diminishes maximum C4 consumption, particularly by smaller immune complexes.

Conclusions:

• C1-In acts as a critical barrier to complement activation by soluble immune complexes.
• C1-In deficiency likely enhances complement activation by immune complexes.
• This mechanism may contribute to the pathogenesis of autoimmune diseases.